正海生物：上半年公司的收入下滑主要受口腔板块的收入下滑影响

Core Viewpoint - The company reported a decline in revenue for the first half of the year, primarily due to a downturn in the oral segment, driven by weak demand in the implant market, increasing competition, and falling product prices [1] Group 1: Revenue Performance - The company's revenue decline was significantly impacted by the oral segment, particularly the revenue from oral repair membranes, which saw a year-on-year decrease [1] - The overall revenue pressure was also influenced by adjustments in tax rates [1] Group 2: Future Strategy - The company plans to continue focusing on its advantageous areas and aims to consistently incubate new products to achieve stable revenue growth in the future [1]